CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 80 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,256,645 | +786.9% | 84,282 | +418.7% | 0.03% | +900.0% |
| Q1 2023 | $141,691 | +25.1% | 16,249 | -10.1% | 0.00% | 0.0% |
| Q4 2022 | $113,305 | +163.5% | 18,071 | +24.8% | 0.00% | +200.0% |
| Q2 2022 | $43,000 | -92.3% | 14,479 | -90.9% | 0.00% | -97.4% |
| Q2 2020 | $557,000 | +75.7% | 159,465 | -25.6% | 0.04% | +46.2% |
| Q1 2020 | $317,000 | +131.4% | 214,436 | +700.4% | 0.03% | +100.0% |
| Q3 2019 | $137,000 | -66.1% | 26,790 | -46.5% | 0.01% | -80.6% |
| Q3 2017 | $404,000 | +861.9% | 50,077 | +128.7% | 0.07% | +235.0% |
| Q3 2015 | $42,000 | – | 21,897 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |